Valant Problems in 2026: BBB F Rating, System Downtime, and PE Acquisition Risks for Behavioral Health Practices
Valant is a behavioral health EHR built primarily for psychiatry practices, with strengths in medication management and TMS workflows. But a pattern of user-reported issues — a BBB F rating, periodic system downtime, clinical form frustrations, and a 2023 private equity acquisition — raises questions about whether the platform can keep pace with the demands of growing behavioral health organizations.
Key Issues at a Glance
- 1BBB F rating — not accredited, 3 of 11 complaints left unanswered
- 2System downtime — approximately once per year the system freezes or goes down for several hours, locking users out
- 3Unwieldy clinical forms: interface lacks logical flow, leading to frustration and longer adaptation periods
- 4Bugs and slowdowns: recurring performance issues during updates and high-traffic periods
- 5PE acquisition (Dec 2023): Resurgens Technology Partners ownership introduces pricing, support, and product trajectory risks
Overview of reported issues
This analysis is based on verified user reviews from Capterra, G2, Software Advice, and Better Business Bureau records. We've organized the most frequently reported issues into seven categories.
Important context: Valant still serves solo psychiatrists and small psychiatry-focused practices well, particularly those relying on its TMS management and deep medication management workflows. The issues documented here primarily affect growing group practices, multi-discipline organizations, and practices that need responsive support and consistent system reliability.
Issue Severity Assessment
Valant EHR Review — Well Suited for Solo Practice and Expanding to Other Clinicians
BBB F rating and unanswered complaints
Valant holds an F rating from the Better Business Bureau and is not BBB-accredited. According to BBB records, 11 complaints have been filed against Valant, of which 3 remain unanswered — a key factor driving the F rating.
For healthcare practices evaluating EHR vendors, BBB ratings serve as a proxy for how a company handles disputes and customer grievances. An F rating with unanswered complaints signals a pattern of unresponsiveness that extends beyond typical software bugs:
- 3 unanswered complaints out of 11 total filed with the BBB
- Not BBB-accredited — meaning Valant has not committed to BBB's standards for trust
- Complaints relate to billing disputes, service issues, and difficulty reaching resolution
Valant BBB Complaint Summary
F
BBB Rating
11
Total Complaints
3
Unanswered
Source: BBB Valant Profile
System downtime and reliability
Users report that approximately once per year, the Valant system freezes up or goes down for several hours. During these outages, clinicians are unable to log into the EMR — meaning they cannot access patient records, document sessions, verify medications, or process billing.
For behavioral health practices, system downtime is not merely an inconvenience — it's a clinical risk:
- Loss of access to medication records during prescribing creates patient safety concerns
- Cancelled or disrupted sessions result in direct revenue loss and schedule chaos
- Documentation backlog: hours of downtime create a documentation pileup that takes days to clear
- Users report the EMR has "not allowed them to log in, causing significant losses"
While no cloud-based EHR guarantees 100% uptime, practices need to evaluate whether annual multi-hour outages align with their operational risk tolerance — particularly for practices managing high-acuity populations or controlled substance prescribing.
Clinical form and interface issues
A recurring theme in user reviews is that Valant's clinical forms are unwieldy and lack logical flow. The interface is described as not always intuitive, leading to:
- Longer adaptation periods: New clinicians require extended onboarding time to become productive
- Initial frustration: Form layouts do not follow natural clinical workflows, causing confusion
- Documentation inefficiency: Clinicians spend more time navigating the interface than documenting care
- Training burden: Practices must invest more in internal training to compensate for unintuitive design
For solo practitioners who learn the system once, this is a manageable annoyance. For growing group practices onboarding new clinicians regularly, unintuitive form design becomes a recurring operational cost.
Bug and performance problems
Many users report encountering bugs or performance slowdowns, particularly during two scenarios:
- After system updates: New releases sometimes introduce regressions that disrupt daily workflows
- During high-traffic periods: The system can slow down when many users are active simultaneously
Performance issues compound the clinical form frustrations — when an already non-intuitive interface also runs slowly, clinician productivity drops further. For practices billing by the encounter, slower systems directly impact revenue capacity.
Customer support frustrations
Customer support is a consistent pain point in Valant user reviews. The primary complaints include:
- Slow response times: Users report waiting extended periods for issue resolution
- Email-first preference: Valant's support team prefers email communication over phone support, frustrating users dealing with complex or urgent issues that require real-time troubleshooting
- Accounting department issues: The accounting/billing support team is specifically called out as difficult to work with
- Complex issues drag on: Without phone-based support for nuanced problems, resolution cycles stretch across multiple email exchanges spanning days or weeks
For a clinical software platform where system issues directly impact patient care and revenue, the inability to reach support by phone for complex problems is a meaningful operational risk.
Private equity acquisition concerns
In December 2023, Valant was acquired by Resurgens Technology Partners, a private equity firm. While PE acquisitions don't guarantee negative outcomes, the pattern across healthcare software is well-documented:
- Pricing pressure: PE firms typically target margin expansion, which often translates to price increases for existing customers
- Support cost-cutting: Customer support is frequently a target for cost reduction post-acquisition
- Product development shifts: R&D investment may redirect from feature development to revenue optimization
- Integration risk: PE portfolios often merge acquired companies with other holdings, potentially disrupting product continuity
Given that Valant already has documented customer support and reliability issues before the full effects of PE ownership typically materialize, practices should monitor whether these issues improve or deteriorate over the coming months.
G2 vs Capterra rating disparity
One of the most telling data points about Valant is the significant gap between its Capterra and G2 ratings:
A 0.9-point gap between major review platforms is unusual and suggests that user experience varies significantly depending on practice type, size, and workflow needs. Practices that align closely with Valant's core psychiatry focus may rate it well, while those pushing the platform beyond its sweet spot encounter the frustrations documented throughout this article.
This rating disparity is worth investigating before committing. The Capterra 4.1 reflects the platform's strengths for its core use case. The G2 3.2 reflects the experience of users encountering its limitations.
What to look for in an alternative
If the issues documented above are affecting your practice, here are the capabilities to prioritize when evaluating alternative behavioral health EHR platforms:
- Proven system reliability: Ask vendors about uptime SLAs and request historical uptime data. Cloud-native architectures with high-availability design should be table stakes for any clinical platform.
- Configurable clinical forms: Evaluate how easily forms can be customized to match your clinical workflows. Rigid, unintuitive layouts slow down clinicians and increase onboarding time for new hires.
- Responsive, multi-channel support: Look for vendors that offer phone and email support with dedicated account management -- not email-only ticketing systems that drag out resolution cycles.
- Ownership and financial stability: Understand who owns the company and whether recent or pending acquisitions could affect pricing, support quality, or product direction.
- AI-assisted documentation: Modern platforms increasingly offer voice-to-note and AI-assisted documentation that can significantly reduce clinician documentation time.
- Group therapy and multi-discipline support: If your practice spans psychiatry, therapy, and group programming, verify the platform handles group notes and multi-discipline workflows natively.
- Facility-level billing (UB-04): Growing organizations that operate residential or facility-based programs need UB-04 billing in addition to CMS-1500. Confirm billing capabilities before committing.
For a side-by-side look at platforms built for these workflows, see our behavioral health EHR comparison and the alternatives guide.
Who should stay with Valant
Valant remains a reasonable choice for:
- Solo psychiatrists who have already adapted to the interface and rely on Valant's deep medication management workflows
- Small psychiatry practices that depend on TMS management features, where Valant's specialty focus outweighs its operational limitations
- Practices where medication management depth is the primary clinical workflow and other limitations are tolerable trade-offs
If your practice is a small psychiatry group, your clinicians have already navigated the learning curve, and you rely heavily on TMS or advanced medication management features, the switching cost may not be justified — especially if you haven't experienced the downtime or support issues firsthand.
However, if you're a growing multi-discipline behavioral health organization, you need responsive support for urgent issues, you're concerned about the trajectory under PE ownership, or you need capabilities like group therapy, AI documentation, integrated CRM, or facility-level billing, the limitations documented here become real operational constraints. In that case, exploring our alternatives guide or behavioral health EHR comparison is a practical next step.
Frequently asked questions
What are the most common Valant complaints in 2026?
The most frequently reported issues are a BBB F rating with unanswered complaints, periodic system downtime lasting several hours, unwieldy clinical forms lacking logical flow, bugs and performance slowdowns during updates, slow customer support that prefers email over phone, and concerns about the December 2023 private equity acquisition by Resurgens Technology Partners.
Does Valant have a good BBB rating?
No. Valant holds an F rating from the Better Business Bureau and is not BBB-accredited. Of 11 complaints filed, 3 remain unanswered — which is the primary factor driving the F rating.
Who acquired Valant and when?
Valant was acquired by Resurgens Technology Partners in December 2023. Resurgens is a private equity firm, and the acquisition introduces concerns about potential pricing changes, support quality shifts, and product development trajectory changes typical of PE-owned healthcare software.
Why is Valant rated so differently on G2 vs Capterra?
Valant has a 4.1/5 rating on Capterra but only a 3.2/5 on G2 — a significant 0.9-point gap. This disparity suggests inconsistent user experience, where some practices find the platform adequate while others encounter frustrating limitations around clinical form design, system reliability, and customer support responsiveness.
Editorial Standards
Last reviewed:
Methodology
- Analyzed verified user reviews from Capterra, G2, and Software Advice (2024-2026).
- Cross-referenced BBB complaint records and rating data.
- Verified PE acquisition details against public reporting.
- Acknowledged Valant strengths for solo psychiatry and TMS-focused use cases.